Kobayashi Pharmaceutical ... (KBYPF)

PNK: KBYPF · Real-Time Price · USD

37.43

0.00 (0.00%)

At close: Apr 30, 2025, 8:00 PM

Kobayashi Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	50.87B	71.54B	96.23B	95.02B	78.25B	75.58B	74.46B	64.99B	58.17B
Short-Term Investments	14.87B	8.3B	8.3B	14.02B	16.09B	14.98B	8.3B	8.3B	5.5B
Long-Term Investments	9.74B	36.08B	20.21B	15.44B	18.39B	24.56B	37.62B	38.5B	46.98B
Other Long-Term Assets	19.94B	3.78B	12.89B	18.55B	20.69B	19.81B	13.87B	14.4B	557M
Receivables	49.44B	52.98B	47.85B	55.15B	52.83B	54.77B	53.26B	50B	47B
Inventory	24.16B	22.08B	17.68B	15.11B	14.14B	15.09B	13.64B	13.29B	12.8B
Other Current Assets	5.12B	3.43B	2.83B	2.59B	2.92B	2.3B	5.4B	5.77B	5.17B
Total Current Assets	144.47B	158.33B	172.89B	181.89B	164.22B	162.71B	155.06B	142.35B	128.65B
Property-Plant & Equipment	67.45B	47.66B	34.78B	22.52B	20.82B	21.18B	19.02B	18.25B	17.83B
Goodwill & Intangibles	20.67B	21.61B	13.31B	12.66B	12.79B	3.11B	4.82B	4.8B	7.22B
Total Long-Term Assets	120.9B	109.14B	82.93B	70.66B	74.14B	70.68B	75.93B	76.48B	72.59B
Total Assets	265.37B	267.47B	255.83B	252.55B	238.37B	233.4B	230.99B	218.83B	201.23B
Account Payables	8.26B	8.74B	18.06B	17.44B	15.93B	17.11B	17.78B	17.5B	16.02B
Deferred Revenue	n/a	n/a	27.87B	28.15B	29.55B	34.02B	34.77B	34.43B	n/a
Short-Term Debt	n/a	n/a	n/a	1M	13M	19M	506M	194M	192M
Other Current Liabilities	18.44B	35.72B	30.94B	30.6B	31.2B	33.74B	34.52B	34.27B	29.56B
Total Current Liabilities	46.42B	56.11B	51.81B	50.7B	50.11B	53.43B	55.22B	54.27B	46.98B
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.42B	5B	3.55B	3.77B	3.21B	4.49B	4.07B	7.3B	10.36B
Total Long-Term Liabilities	5.47B	6.55B	6.12B	6.25B	5.68B	7.31B	9.53B	10.75B	10.94B
Total Liabilities	51.9B	62.66B	57.93B	56.95B	55.78B	60.74B	64.74B	65.02B	57.91B
Total Debt	846M	987M	792M	630M	688M	891M	1.03B	776M	773M
Common Stock	3.45B	3.45B	3.45B	3.45B	3.45B	3.45B	3.45B	3.45B	3.45B
Retained Earnings	208.24B	205.68B	194.28B	200.53B	187.07B	173.65B	159.86B	146.76B	147.9B
Comprehensive Income	n/a	n/a	14.12B	11.14B	7.64B	11.14B	10.52B	11.68B	8.1B
Shareholders Equity	213.47B	204.82B	197.9B	195.6B	182.58B	172.66B	166.25B	153.81B	143.24B
Total Investments	24.62B	32.12B	28.51B	29.47B	34.47B	39.53B	45.92B	46.8B	52.48B